Back to results

CompletedN/A

InSync III Marquis Model 7279 Cardioverter Defibrillator Cardiac Resynchronization System

NCT00271232

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Anchorage, Alaska, United States

+33 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2003-03
Enrollment: 238 participants
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Purpose: treatment

Locations (34)

Anchorage, Alaska, United States
Phoenix, Arizona, United States
Los Angeles, California, United States
Stanford, California, United States
Jacksonville, Florida, United States
Pensacola, Florida, United States
Tampa, Florida, United States
Atlanta, Georgia, United States
Beech Grove, Indiana, United States
Burlington, Massachusetts, United States
Minneapolis, Minnesota, United States
Saint Paul, Minnesota, United States
Kansas City, Missouri, United States
Lincoln, Nebraska, United States
Las Vegas, Nevada, United States
Lebanon, New Hampshire, United States
New York, New York, United States
Rochester, New York, United States
Syracuse, New York, United States
Raleigh, North Carolina, United States
Cincinnati, Ohio, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Lancaster, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Wynnewood, Pennsylvania, United States
Aiken, South Carolina, United States
Columbia, South Carolina, United States
Memphis, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Dallas, Texas, United States
Falls Church, Virginia, United States
Milwaukee, Wisconsin, United States

InSync III Marquis Model 7279 Cardioverter Defibrillator Cardiac Resynchronization System — TrialFind